David Cameron Pryde
14Patents
4h-index
44Co-inventors
56Inventor score
Filing activity: Mar 12, 2002 → Jun 21, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6660756B2 | N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase | Chemistry; Metallurgy | 83 | Expired |
| US7642350B2 | Purine derivatives | Chemistry; Metallurgy | 67 | Active |
| US7691877B2 | Pharmaceuticals | Chemistry; Metallurgy | 25 | Active |
| US9216229B2 | IgE CH3 peptide vaccine | Human Necessities | 7 | Active |
| US8298547B2 | IgE CH3 peptide vaccine | Human Necessities | 4 | Active |
| US8980276B2 | Conjugates for the prevention or treatment of nicotine addiction | Emerging Cross-Sectional Technologies | 3 | Active |
| US8952008B2 | Chemical compounds | Human Necessities | 1 | Active |
| US8475801B2 | IgE CH3 peptide vaccine | Human Necessities | 1 | Active |
| US6849649B2 | N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase | Chemistry; Metallurgy | 0 | Expired |
| US11571423B2 | Small molecule modulators of human sting | Chemistry; Metallurgy | 0 | Active |
| US9802945B2 | Imidazopyridazine derivatives as modulators of the GABAA receptor activity | Human Necessities | 0 | Active |
| US9447116B2 | Inhibitors of HIV replication | Chemistry; Metallurgy | 0 | Active |
| US8809363B2 | Inhibitors of HIV replication | Chemistry; Metallurgy | 0 | Active |
| US10538523B2 | 4-(biphen-3-yl)-1H-pyrazolo[3,4-c]pyridazine derivatives of formula (I) as GABA receptor modulators for use in the treatment of epilepsy and pain | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.